Dhaka, July 7 -- CRISPR technology is transforming modern medicine by enabling precise DNA editing to treat genetic disorders, including sickle cell anemia and beta-thalassemia, experts say.

CRISPR, short for Clustered Regularly Interspaced Short Palindromic Repeats, was initially discovered as part of a bacterial defense system.

Scientists have since repurposed it into a powerful gene-editing tool that uses a Cas nuclease enzyme guided by programmable RNA to make highly accurate cuts in DNA, allowing precise genetic modifications at specific points in the genome.

According to the US National Institutes of Health (NIH), CRISPR/Cas9 is revolutionizing biomedical research by providing a fast, affordable, and highly precise method to corr...